Fischer Medical subsidiary launches low-field MRI for aneurysm screening
Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited, announced the launch of VEGA, a new low-field TOF MRI system. This platform is specifically engineered for rapid, non-contrast TOF angiographic screening of unruptured intracranial aneurysms and was developed in collaboration with neurosurgeon Dr. Iype Cherian.
The VEGA system uses a permanent-magnet low-field design, eliminating the need for helium and significantly reducing power consumption and maintenance. It produces high-quality vascular imaging within six minutes, without radiation or contrast, making it suitable for deployment in district hospitals, semi-urban clinics, and mobile diagnostic units. Artificial intelligence models are integrated to detect aneurysms on TOF scans with over 95% sensitivity, facilitating large-scale screening.
Unruptured intracranial aneurysms affect approximately 3.2% of adults globally, translating to nearly 30 million people in India. Early detection is crucial, as ruptured aneurysms result in 26-45% mortality. This new platform aims to address India's substantial opportunity for neurovascular screening, with an estimated 700 million people over 40 years old.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when FISCHER MEDICAL VENTURES publishes news
Free account required • Unsubscribe anytime